SCHEMBL7780798

SCHEMBL7780798

Cc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)n[nH]c2C(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.46
CA1 P00915 4/20 0.46
CA2 P00918 4/20 0.46
CA9 Q16790 4/20 0.46
CA3 P07451 2/20 0.46
CA6 P23280 2/20 0.46
CA5A P35218 2/20 0.46
CA7 P43166 2/20 0.46
CA5B Q9Y2D0 2/20 0.46
PTGS2 P35354 9/20 0.46
PTGS1 P23219 4/20 0.46
LRRK2 Q5S007 6/20 0.46
MAP2K7 O14733 1/20 0.45
MAP2K4 P45985 1/20 0.45
MT-CO2 P00403 1/20 0.42
LMNA P02545 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADORA3 P0DMS8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779480 0.88 PTGS2 (0.45) PTGS2PTGS1LRRK2
SCHEMBL7772883 0.87 PTGS2 (0.47) CA12CA1CA2CA9CA3
SCHEMBL8759061 0.84 LRRK2 (0.43) CA12CA1CA2CA9CA3
SCHEMBL8632836 0.81 LRRK2 (0.45) CA12CA2CA9PTGS2PTGS1
SCHEMBL8758740 0.80 LRRK2 (0.42) CA12CA1CA2CA9CA3
SCHEMBL7777620 0.80 LRRK2 (0.60) CA12CA1CA2CA9CA3
SCHEMBL7773229 0.78 LRRK2 (0.50) CA12CA1CA2CA9CA3
SCHEMBL7777685 0.78 LRRK2 (0.50) CA12CA1CA2CA9CA3
SCHEMBL7780566 0.77 CA9 (0.51) CA12CA1CA2CA9CA3
SCHEMBL7779303 0.77 PTGS2 (0.51) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed